1. Home
  2. TSBX vs SYNX Comparison

TSBX vs SYNX Comparison

Compare TSBX & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • SYNX
  • Stock Information
  • Founded
  • TSBX 2015
  • SYNX 2005
  • Country
  • TSBX United States
  • SYNX Israel
  • Employees
  • TSBX N/A
  • SYNX N/A
  • Industry
  • TSBX
  • SYNX
  • Sector
  • TSBX
  • SYNX
  • Exchange
  • TSBX Nasdaq
  • SYNX Nasdaq
  • Market Cap
  • TSBX 8.4M
  • SYNX 9.7M
  • IPO Year
  • TSBX 2023
  • SYNX 2024
  • Fundamental
  • Price
  • TSBX $0.32
  • SYNX $1.85
  • Analyst Decision
  • TSBX Buy
  • SYNX
  • Analyst Count
  • TSBX 3
  • SYNX 0
  • Target Price
  • TSBX $4.75
  • SYNX N/A
  • AVG Volume (30 Days)
  • TSBX 89.5K
  • SYNX 26.6K
  • Earning Date
  • TSBX 05-12-2025
  • SYNX 05-21-2025
  • Dividend Yield
  • TSBX N/A
  • SYNX N/A
  • EPS Growth
  • TSBX N/A
  • SYNX N/A
  • EPS
  • TSBX N/A
  • SYNX N/A
  • Revenue
  • TSBX N/A
  • SYNX $9,893,000.00
  • Revenue This Year
  • TSBX N/A
  • SYNX $52.34
  • Revenue Next Year
  • TSBX N/A
  • SYNX N/A
  • P/E Ratio
  • TSBX N/A
  • SYNX N/A
  • Revenue Growth
  • TSBX N/A
  • SYNX 18.05
  • 52 Week Low
  • TSBX $0.29
  • SYNX $1.71
  • 52 Week High
  • TSBX $3.39
  • SYNX $6.49
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 32.89
  • SYNX 33.15
  • Support Level
  • TSBX $0.29
  • SYNX $1.74
  • Resistance Level
  • TSBX $0.41
  • SYNX $1.90
  • Average True Range (ATR)
  • TSBX 0.03
  • SYNX 0.16
  • MACD
  • TSBX -0.01
  • SYNX 0.04
  • Stochastic Oscillator
  • TSBX 23.39
  • SYNX 36.39

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat-proven. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both in training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, market and sell push-to-talk devices, communication controllers, and communication device cables and connectors.

Share on Social Networks: